Research Paper Volume 13, Issue 4 pp 5928—5945

Cell differentiation trajectory predicts patient potential immunotherapy response and prognosis in gastric cancer

Expression levels of 38 ICGs across three molecular subtypes and prognostic analysis. (A) Differential expression analysis of 38 ICGs. (B) Kaplan-Meier analysis of CD80, CTLA4, TNFRSF9, IFNG, LDHA and TNFSF9. (C) Kaplan-Meier analysis of VTCN1, JAK1 and LAMA3. (D) Kaplan-Meier analysis of LDHB, TNFSF4 and PTPRC. ICGs: immune checkpoint genes.

Figure 5. Expression levels of 38 ICGs across three molecular subtypes and prognostic analysis. (A) Differential expression analysis of 38 ICGs. (B) Kaplan-Meier analysis of CD80, CTLA4, TNFRSF9, IFNG, LDHA and TNFSF9. (C) Kaplan-Meier analysis of VTCN1, JAK1 and LAMA3. (D) Kaplan-Meier analysis of LDHB, TNFSF4 and PTPRC. ICGs: immune checkpoint genes.